Table 3.
Institute | Study cohort |
Cases identified (n=450) | Number of controls matched | |
|
|
|
Controls identified within same cohort (n=801) | Controls identified within DCOG LATER cohort (n=81) |
DCOG LATER | DCOG LATER cohort | 120 | 238 | N/Aa |
Westfaelische Wilhelms-Universitaet Muenster | Ewing 2008 Clinical Trials cohort | 8 | 15 | 0 |
Fakultni Nemocinice Brno | Cohort malignant cancer survivors Brno | 17 | 30 | 3 |
Fakultni Nemocnice v Motol | Cohort malignant cancer survivors Motol | 128 | 232 | 19 |
Istituto Giannina Gaslini | Gasline female survivors cohort | 91 | 179 | 2 |
Great Ormond Street Children’s Hospital and University College London Hospital | Hematopoietic stem cell transplantation cohort | 28 | 6 | 43 |
Oslo University Hospital | Lymphoma survivor cohort and Acute lymphoblastic leukemia survivor cohort | 18 | 24 | 12 |
University hospital Saint-Étienne | Rhone Alpe cohort 1 and Rhone Alpe cohort 2 | 28 | 56 | 0 |
Edmond and Lily Safra Children’s Hospital, Sheba Medical Center | The Edmond and Lily Safra Children’s Hospital Late Effects cohort | 12 | 21 | 2 |
aN/A: Not applicable.